Global Erectile Dysfunction Market Growth 2025-2031

Publication ID:

LPI04250495

Publication Date:

April 17, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Erectile Dysfunction market size is predicted to grow from US$ 6595 million in 2025 to US$ 10070 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The erectile dysfunction (ED) drug market is experiencing significant growth. The main drivers of market growth include the increase in the elderly population, increased awareness of ED, innovation in treatment methods, and favorable reimbursement policies.
The prevalence of ED is rising globally, with an estimated 15% of men affected by ED each year and expected to affect 320 million people by 2025. The incidence of ED increases with age, and the growth of the elderly population is one of the key factors driving the growth of the ED drugs market.
Technological advancements such as new drug development, innovations in drug delivery systems such as sublingual tablets, topical creams, and nasal sprays are also driving market growth. Additionally, the rise of telemedicine services is changing how ED treatment is obtained.
The market is highly concentrated, with major players including Bayer, Eli Lilly, Pfizer, Teva and other companies. These companies strengthen their market positions by launching new drugs, expanding product portfolios and market coverage.
In terms of products, sildenafil (Viagra) held the largest market share in 2023, followed by tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra).
In terms of route of administration, oral drugs accounted for the largest market share in 2023, and other routes, including topical and intraurethral delivery, are expected to grow at the fastest rate.
From a regional perspective, North America is the largest market, accounting for more than 40% of the market share, followed by Asia Pacific and Europe.
Overall, the ED drugs market is driven by several factors, including increasing geriatric population, changing lifestyles, technological advancements, and rising awareness about ED treatments. The market is expected to continue to expand as new drugs and new treatment modalities are developed.
The 鈥淓rectile Dysfunction Industry Forecast鈥� looks at past sales and reviews total world Erectile Dysfunction sales in 2024, providing a comprehensive analysis by region and market sector of projected Erectile Dysfunction sales for 2025 through 2031. With Erectile Dysfunction sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Erectile Dysfunction industry.
This Insight Report provides a comprehensive analysis of the global Erectile Dysfunction landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Erectile Dysfunction portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Erectile Dysfunction market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Erectile Dysfunction and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Erectile Dysfunction.
This report presents a comprehensive overview, market shares, and growth opportunities of Erectile Dysfunction market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Sildenafil
Tadalafil
Others
Segmentation by Application:
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy
Key Questions Addressed in this Report
What is the 10-year outlook for the global Erectile Dysfunction market?
What factors are driving Erectile Dysfunction market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Erectile Dysfunction market opportunities vary by end market size?
How does Erectile Dysfunction break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Erectile Dysfunction Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Erectile Dysfunction by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Erectile Dysfunction by Country/Region, 2020, 2024 & 2031
2.2 Erectile Dysfunction Segment by Type
2.2.1 Sildenafil
2.2.2 Tadalafil
2.2.3 Others
2.3 Erectile Dysfunction Sales by Type
2.3.1 Global Erectile Dysfunction Sales Market Share by Type (2020-2025)
2.3.2 Global Erectile Dysfunction Revenue and Market Share by Type (2020-2025)
2.3.3 Global Erectile Dysfunction Sale Price by Type (2020-2025)
2.4 Erectile Dysfunction Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Private Clinics
2.4.3 Retail Pharmacies
2.4.4 E-Commerce (B2B)
2.4.5 E-Commerce (B2C)
2.5 Erectile Dysfunction Sales by Application
2.5.1 Global Erectile Dysfunction Sale Market Share by Application (2020-2025)
2.5.2 Global Erectile Dysfunction Revenue and Market Share by Application (2020-2025)
2.5.3 Global Erectile Dysfunction Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Erectile Dysfunction Breakdown Data by Company
3.1.1 Global Erectile Dysfunction Annual Sales by Company (2020-2025)
3.1.2 Global Erectile Dysfunction Sales Market Share by Company (2020-2025)
3.2 Global Erectile Dysfunction Annual Revenue by Company (2020-2025)
3.2.1 Global Erectile Dysfunction Revenue by Company (2020-2025)
3.2.2 Global Erectile Dysfunction Revenue Market Share by Company (2020-2025)
3.3 Global Erectile Dysfunction Sale Price by Company
3.4 Key Manufacturers Erectile Dysfunction Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Erectile Dysfunction Product Location Distribution
3.4.2 Players Erectile Dysfunction Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Erectile Dysfunction by Geographic Region
4.1 World Historic Erectile Dysfunction Market Size by Geographic Region (2020-2025)
4.1.1 Global Erectile Dysfunction Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Erectile Dysfunction Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Erectile Dysfunction Market Size by Country/Region (2020-2025)
4.2.1 Global Erectile Dysfunction Annual Sales by Country/Region (2020-2025)
4.2.2 Global Erectile Dysfunction Annual Revenue by Country/Region (2020-2025)
4.3 Americas Erectile Dysfunction Sales Growth
4.4 APAC Erectile Dysfunction Sales Growth
4.5 Europe Erectile Dysfunction Sales Growth
4.6 Middle East & Africa Erectile Dysfunction Sales Growth
5 Americas
5.1 Americas Erectile Dysfunction Sales by Country
5.1.1 Americas Erectile Dysfunction Sales by Country (2020-2025)
5.1.2 Americas Erectile Dysfunction Revenue by Country (2020-2025)
5.2 Americas Erectile Dysfunction Sales by Type (2020-2025)
5.3 Americas Erectile Dysfunction Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Erectile Dysfunction Sales by Region
6.1.1 APAC Erectile Dysfunction Sales by Region (2020-2025)
6.1.2 APAC Erectile Dysfunction Revenue by Region (2020-2025)
6.2 APAC Erectile Dysfunction Sales by Type (2020-2025)
6.3 APAC Erectile Dysfunction Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Erectile Dysfunction by Country
7.1.1 Europe Erectile Dysfunction Sales by Country (2020-2025)
7.1.2 Europe Erectile Dysfunction Revenue by Country (2020-2025)
7.2 Europe Erectile Dysfunction Sales by Type (2020-2025)
7.3 Europe Erectile Dysfunction Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Erectile Dysfunction by Country
8.1.1 Middle East & Africa Erectile Dysfunction Sales by Country (2020-2025)
8.1.2 Middle East & Africa Erectile Dysfunction Revenue by Country (2020-2025)
8.2 Middle East & Africa Erectile Dysfunction Sales by Type (2020-2025)
8.3 Middle East & Africa Erectile Dysfunction Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Erectile Dysfunction
10.3 Manufacturing Process Analysis of Erectile Dysfunction
10.4 Industry Chain Structure of Erectile Dysfunction
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Erectile Dysfunction Distributors
11.3 Erectile Dysfunction Customer
12 World Forecast Review for Erectile Dysfunction by Geographic Region
12.1 Global Erectile Dysfunction Market Size Forecast by Region
12.1.1 Global Erectile Dysfunction Forecast by Region (2026-2031)
12.1.2 Global Erectile Dysfunction Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Erectile Dysfunction Forecast by Type (2026-2031)
12.7 Global Erectile Dysfunction Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Erectile Dysfunction Product Portfolios and Specifications
13.1.3 Eli Lilly Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Erectile Dysfunction Product Portfolios and Specifications
13.2.3 Pfizer Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Erectile Dysfunction Product Portfolios and Specifications
13.3.3 Bayer Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 BaiYunShan General Factory
13.4.1 BaiYunShan General Factory Company Information
13.4.2 BaiYunShan General Factory Erectile Dysfunction Product Portfolios and Specifications
13.4.3 BaiYunShan General Factory Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 BaiYunShan General Factory Main Business Overview
13.4.5 BaiYunShan General Factory Latest Developments
13.5 S.K. Chemicals
13.5.1 S.K. Chemicals Company Information
13.5.2 S.K. Chemicals Erectile Dysfunction Product Portfolios and Specifications
13.5.3 S.K. Chemicals Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 S.K. Chemicals Main Business Overview
13.5.5 S.K. Chemicals Latest Developments
13.6 Teva Pharma
13.6.1 Teva Pharma Company Information
13.6.2 Teva Pharma Erectile Dysfunction Product Portfolios and Specifications
13.6.3 Teva Pharma Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teva Pharma Main Business Overview
13.6.5 Teva Pharma Latest Developments
13.7 Dong-A ST
13.7.1 Dong-A ST Company Information
13.7.2 Dong-A ST Erectile Dysfunction Product Portfolios and Specifications
13.7.3 Dong-A ST Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dong-A ST Main Business Overview
13.7.5 Dong-A ST Latest Developments
13.8 Petros Pharmaceuticals
13.8.1 Petros Pharmaceuticals Company Information
13.8.2 Petros Pharmaceuticals Erectile Dysfunction Product Portfolios and Specifications
13.8.3 Petros Pharmaceuticals Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Petros Pharmaceuticals Main Business Overview
13.8.5 Petros Pharmaceuticals Latest Developments
13.9 Seoul Pharma
13.9.1 Seoul Pharma Company Information
13.9.2 Seoul Pharma Erectile Dysfunction Product Portfolios and Specifications
13.9.3 Seoul Pharma Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Seoul Pharma Main Business Overview
13.9.5 Seoul Pharma Latest Developments
13.10 Yabang Pharmacy
13.10.1 Yabang Pharmacy Company Information
13.10.2 Yabang Pharmacy Erectile Dysfunction Product Portfolios and Specifications
13.10.3 Yabang Pharmacy Erectile Dysfunction Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Yabang Pharmacy Main Business Overview
13.10.5 Yabang Pharmacy Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂